Healthcare - Medical - Devices - NASDAQ - US
$ 2.84
-8.97 %
$ 13.5 M
Market Cap
-0.42
P/E
INCOME STATEMENT
13.8 M
REVENUE
-17.3 M
OPERATING INCOME
-13.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Vivos Therapeutics, Inc.
| Revenue | 13.8 M |
| Cost Of Revenue | 5.53 M |
| Gross Profit | 8.27 M |
| Operating Expenses | 24.9 M |
| Operating Income | -17.3 M |
| Other Expenses | -3.71 M |
| Net Income | -13.6 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 13.8 | 16.0 | 16.9 | 13.1 | 11.4 | 3.8 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 5.5 | 6.0 | 4.3 | 2.7 | 2.7 | 1.1 |
| Gross Profit | 8.3 | 10.0 | 12.6 | 10.4 | 8.7 | 2.7 |
| OPERATING INCOME | ||||||
| Operating Expenses | 24.9 | 35.0 | 32.1 | 19.1 | 19.2 | 11.0 |
| Selling, General and Administrative Expenses | 24.8 | 34.4 | 31.3 | 18.4 | 18.5 | 10.4 |
| Research and Development Expenses | 100 K | 0.2 | 0 | 0 | 0 | 0 |
| Operating Income | (17.3) | (25.0) | (19.5) | (8.7) | (10.6) | (8.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 14 K | 96.7 K | 0.1 | 0.1 |
| Total Other Income | 3.7 | 1.2 | 94 K | 16.9 K | (0.2) | (0.1) |
| Pre-Tax Income | (13.6) | (23.8) | (20.3) | (12.1) | (10.8) | (8.4) |
| NET INCOME | ||||||
| Tax Provision | 0 | (1.2) | 5 K | (3.2) | 0.1 | 0.1 |
| Net Income | (13.6) | (22.7) | (20.3) | (8.8) | (10.9) | (8.5) |
| EPS | 11.1 | 24.6 | 23.9 | 12.1 | 15 | 18.5 |